Acuere Biosciences

Acuere Biosciences is a Salt Lake City-based biotechnology company specializing in the discovery and development of innovative small molecule drugs for oncology and inflammatory disorders. Founded in 2020 by a veteran team of drug hunters previously behind Tolero Pharmaceuticals, the company utilizes a proprietary structure-based drug discovery platform to target complex biological pathways. Acuere's research is particularly focused on the tumor microenvironment and mechanisms of therapeutic resistance, aiming to develop precision medicines that offer improved outcomes for patients. The company's pipeline consists of several pre-clinical programs, leveraging advanced computational tools to optimize lead compounds. As a private enterprise, Acuere Biosciences continues to expand its portfolio through internal research and strategic collaborations within the life sciences ecosystem.